Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 40Colorectal Neoplasms 24Carcinoma, Non-Small-Cell Lung 18Rectal Neoplasms 14Lung Neoplasms 13Stomach Neoplasms 12Esophageal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 9Esophageal Squamous Cell Carcinoma 9Prostatic Neoplasms 8Pancreatic Neoplasms 8Neoplasm Metastasis 8Colonic Neoplasms 8Carcinoma, Hepatocellular 8Adenocarcinoma Of Esophagus 8Ovarian Neoplasms 7Sarcoma 6Neoplasms 6Head and Neck Neoplasms 6Urinary Bladder Neoplasms 5Osteosarcoma 5Liver Neoplasms 5Kidney Neoplasms 4Inflammatory Breast Neoplasms 4Fallopian Tube Neoplasms 4Carcinoma, Renal Cell 4Breast Neoplasms, Male 4Turcot syndrome 3Multiple Myeloma 3Locally Advanced Rectal Cancer 3

Interventions

Paclitaxel 12Cisplatin 11Hyperthermic Intraperitoneal Chemotherapy 10Cytoreduction Surgical Procedures 9Oxaliplatin 8Fluorouracil 7Mitomycin 6Carboplatin 5Leucovorin 4Bevacizumab 4catumaxomab 3Doxorubicin 3Docetaxel 3sodium thiosulfate 2Indocyanine Green 2Drug Therapy 2Cetuximab 2volociximab 1vandetanib 1relacorilant 1pasireotide 1nilotinib 1farletuzumab 1epothilone B 1enzastaurin 1birinapant 1alvimopan 1Surgical Procedures, Operative 1Saline Waters 1Platinum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Peritoneal Neoplasms × Neoadjuvant Therapy × Clear all
NCT00112086 2016-08-31

OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206

Japan Clinical Oncology Group

Phase 2 Completed
56 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡